Concepedia

Carol Gleason

CG

34

Publications

1.3K

Citations

20

H-Index

1987

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Pfizer (United States)

United States Food and Drug Administration

Covance (United States)

Carol Gleason is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and clinical chemistry.

Top concepts

Publications per year

1987–2023

34

Publications

34

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

Rashmi H. Barbhaiya, S. Thomas Forgue, Carol Gleason et al. · Antimicrobial Agents and Chemotherapy · 1992 · 125 citations · Full text

, , +13

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 92 citations · Full text

Development and Validation of a Preclinical Food Effect Model

Kimberley A. Lentz, Megan Quitko, Daniel G. Morgan et al. · Journal of Pharmaceutical Sciences · 2006 · 84 citations

, , +5

Correlation between renal membrane binding and nephrotoxicity of aminoglycosides

Patricia D. Williams, Damien Bennett, Carol Gleason et al. · Antimicrobial Agents and Chemotherapy · 1987 · 82 citations

, , +9

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

Rashmi H. Barbhaiya, S. Thomas Forgue, Carol Gleason et al. · Antimicrobial Agents and Chemotherapy · 1990 · 72 citations · Full text

, , +14

Rows per page

1–5 of 34